WASHINGTON — The Drug Enforcement Administration issued a ruling Wednesday, declaring cannabidiol hemp oil a Schedule 1 substance.
That puts CBD oil in the same category as heroin, LSD, MDMA, psilocybin and other drugs.
CBD oil is derived from hemp plants that do not contain a large amount of tetrahydrocannabinol, the psychoactive component in cannabis.
“For practical purposes, all extracts that contain CBD will also contain at least small amounts of other cannabinoids,” the ruling said.
Proponents of CBD oil say it is a strong anti-inflammatory that can be used to manage pain and treat issues ranging from epilepsy to anxiety and post-traumatic stress disorder.
The DEA defines Schedule 1 drugs as “drugs with no currently accepted medical use and a high potential for abuse.”
“A pharmaceutical firm currently involved in cannabinoidal research and product development praised the DEA’s efforts to establish a new drug code for marihuana (sic) extracts,” the DEA said.